Foreign company group no longer interested in new standard for drug price determination.

Published: 1999-10-28 11:56:00

Updated: 1999-10-28 11:56:00

The foreign drug company group has participated in the revising works for the price determination standard of new drugs but seems to withdraw its involvement probably on account of no chances for any desirable achievement.

The MOHW invited foreign representatives to the task force of revising ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK